🇺🇸 FDA
Patent

US 6750226

Quinuclidine derivatives and their use as muscarinic M3 receptor ligands

expired A61KA61K31/439A61K31/4745

Quick answer

US patent 6750226 (Quinuclidine derivatives and their use as muscarinic M3 receptor ligands) held by Almirall Prodesfarma S.A. expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Almirall Prodesfarma S.A.
Grant date
Tue Jun 15 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/439, A61K31/4745, A61K31/56, A61K45/06